DeepMed Research

Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab

Completed

Conditions: Breast Cancer

Interventions: Drug: Pertuzumab Plus Trastuzumab
Drug: Pyrotinib Plus Trastuzumab

First Posted Date: 2022-10-10

Last Posted Date: 2024-02-26

Lead Sponsor: Fudan University

Target Recruit Count: 333

Registration Number: NCT05572645

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

The Rechallenge of ADCs in MBC Patients

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: ADC

First Posted Date: 2022-10-07

Last Posted Date: 2024-10-21

Lead Sponsor: Fudan University

Target Recruit Count: 100

Registration Number: NCT05571618

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients

Not Applicable

Recruiting

Conditions: Luteal Phase Support
Idiopathic Hypogonadotropic Hypogonadism
Luteal Phase Deficiency

Interventions: Drug: Additional hCG injection
Drug: estrogen and dydrogesterone

First Posted Date: 2022-10-06

Last Posted Date: 2024-08-07

Lead Sponsor: Fudan University

Target Recruit Count: 46

Registration Number: NCT05569577

Locations: 🇨🇳
OB & GYN Hospital of Fudan University, Shanghai, Shanghai, China
🇨🇳
Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai, China

The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer

Phase 2

Recruiting

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: Fruquintinib+ chemotherapy
Drug: Bevacizumab+ chemotherapy

First Posted Date: 2022-09-27

Last Posted Date: 2023-08-30

Lead Sponsor: Fudan University

Target Recruit Count: 116

Registration Number: NCT05555901

Locations: 🇨🇳
Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳
the Second Affiliated Hospital of Medical College of Zhejiang University, Hangzhou, Zhejiang, China
🇨🇳
The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang, Hebei, China

and more 10 locations

The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer

Phase 2

Recruiting

Conditions: Early Low Rectal Cancer

Interventions: Drug: PD-1 antibody
Drug: Capecitabine
Drug: Oxaliplatin
Radiation: Short-course radiotherapy

First Posted Date: 2022-09-27

Last Posted Date: 2025-01-15

Lead Sponsor: Fudan University

Target Recruit Count: 34

Registration Number: NCT05555888

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Health-promoting Lifestyle in a Genetic Counseling Clinic

Completed

Conditions: Genetic Testing
Breast Cancer

Interventions: Genetic: genetic testing

First Posted Date: 2022-09-19

Last Posted Date: 2022-09-19

Lead Sponsor: Fudan University

Target Recruit Count: 140

Registration Number: NCT05545254

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer

Phase 3

Recruiting

Conditions: Colorectal Cancer

Interventions: Drug: VIC
Drug: Bevacizumab Plus Chemotherapy

First Posted Date: 2022-09-15

Last Posted Date: 2022-09-15

Lead Sponsor: Fudan University

Target Recruit Count: 78

Registration Number: NCT05540951

Locations: 🇨🇳
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric Cancer

Not Applicable

Completed

Conditions: Gastric Cancer

Interventions: Procedure: laparoscopy-assisted distal gastrectomy Group
Procedure: Totally laparoscopic distal gastrectomy

First Posted Date: 2022-09-15

Last Posted Date: 2025-03-26

Lead Sponsor: Fudan University

Target Recruit Count: 213

Registration Number: NCT05541783

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Laparoscopic vs Open Total Gastrectomy for Gastric Cancer

Not Applicable

Recruiting

Conditions: Gastric Cancer

Interventions: Procedure: Total Gastrectomy

First Posted Date: 2022-09-13

Last Posted Date: 2022-09-13

Lead Sponsor: Fudan University

Target Recruit Count: 600

Registration Number: NCT05537129

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer

Phase 2

Recruiting

Conditions: Bladder Cancer

Interventions: Drug: Tislelizumab
Drug: gemcitabine and cisplatin
Radiation: Modified hypofractionation

First Posted Date: 2022-09-07

Last Posted Date: 2024-07-12

Lead Sponsor: Fudan University

Target Recruit Count: 30

Registration Number: NCT05531123

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy